October 23, 2026

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating the Biotech Waters with a $2.27 Billion Market Cap

Fortrea Holdings Inc. (FTRE) is an intriguing player in the healthcare sector, specifically within the dynamic biotechnology industry. With its roots firmly planted in the United..

Precigen, Inc. (PGEN) Stock Analysis: Unpacking a 113% Potential Upside in Biotech

Precigen, Inc. (NASDAQ: PGEN), a biotech innovator headquartered in Germantown, Maryland, is generating buzz in the healthcare sector with its cutting-edge gene and cell therapies. The..

Talkspace, Inc. (TALK) Stock Analysis: Exploring a 21% Upside Potential with Strong Revenue Growth

For investors seeking exposure in the digital health sector, Talkspace, Inc. (NASDAQ: TALK) presents a compelling opportunity. As a pioneer in virtual behavioral healthcare, Talkspace connects..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: A Healthcare Sector Gem with 46% Upside Potential

Sonida Senior Living, Inc. (NASDAQ: SNDA) stands as a noteworthy player within the healthcare sector, specifically in the niche of medical care facilities. With a market..

MeiraGTx Holdings plc (MGTX): Analyst Ratings Signal a Potential 184% Upside for Biotech Investors

MeiraGTx Holdings plc (NASDAQ: MGTX) is making waves in the biotechnology sector, capturing the attention of investors with its cutting-edge genetic medicines and a standout potential..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 255% Upside for Investors

Sana Biotechnology, Inc. (NASDAQ: SANA) is a compelling player in the biotechnology sector, with a focus on harnessing engineered cells to develop innovative treatments for diseases..

Immatics N.V. (IMTX) Stock Analysis: A Biotech Powerhouse with 128% Upside Potential

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company, is making waves in the biotech sector with its innovative approach to cancer treatment. Headquartered in Tübingen, Germany,..

COMPASS Pathways Plc (CMPS) Investor Outlook: Unpacking the 104% Potential Upside in Mental Health Innovation

In the rapidly evolving field of mental health treatment, COMPASS Pathways Plc (NASDAQ: CMPS) is making waves with its innovative approach. As a biotechnology firm headquartered..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a Promising 941% Upside Potential in Biotechnology

Upstream Bio, Inc. (NASDAQ: UPB) is a clinical-stage biotechnology company focusing on developing innovative treatments for inflammatory diseases, particularly severe respiratory disorders. Headquartered in Waltham, Massachusetts,..

Theravance Biopharma (TBPH) Stock Analysis: A Stable Play with a 3.74% Potential Upside

For investors navigating the healthcare sector, Theravance Biopharma, Inc. (NASDAQ: TBPH) presents a unique opportunity within the biotechnology industry. With a market capitalization of $884.18 million,..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Exploring a Potential 596.67% Upside

Akebia Therapeutics, Inc. (NASDAQ: AKBA) is capturing the attention of investors with a striking potential upside of 596.67%, according to analyst ratings. This biopharmaceutical company, based..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 69.59% Potential Upside in Biotech

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is capturing the attention of investors with its promising position in the biotechnology sector. As a clinical-stage biopharmaceutical company, Zenas BioPharma..

Claritev Corporation (CTEV) Stock Analysis: Healthcare Innovator with Nearly 96% Upside Potential

Claritev Corporation (NASDAQ: CTEV) has emerged as a compelling player in the healthcare sector, specifically within the niche of Health Information Services. As the company continues..

AxoGen, Inc. (AXGN) Stock Analysis: A 45.98% Potential Upside in the Healthcare Sector

AxoGen, Inc. (NASDAQ: AXGN), a pivotal player in the healthcare sector, is making waves in the medical devices industry with its focus on peripheral nerve regeneration..

Embecta Corp. (EMBC) Stock Analysis: Navigating Healthcare Challenges with a 3.89 Forward P/E

Embecta Corp. (NASDAQ: EMBC), a stalwart in the healthcare sector, presents a fascinating case for investors focused on medical instruments and supplies. With its roots tracing..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring an 80% Potential Upside in the Biotech Sector

Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology company, has captured the attention of investors with its promising technology aimed at degrading disease-causing proteins. With a market..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Exploring a 78% Potential Upside in Biotech

Cogent Biosciences, Inc. (NASDAQ: COGT), a clinical-stage biotechnology company, is capturing the attention of investors with its focus on precision therapies for genetically defined diseases. The..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Exploring a 47.92% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology company, is generating buzz among investors with its significant potential upside of 47.92%. This figure is driven by..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a 101% Potential Upside

Vir Biotechnology, Inc. (NASDAQ: VIR), a prominent player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of over 101%. This clinical-stage..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: A Promising Biotech with 144% Potential Upside

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is making waves in the biotechnology sector, offering investors a compelling opportunity with a potential upside of 144.43%, according to analysts’..

Search

Funds

October 23, 2026

Search

Funds

October 23, 2026

FTSE 100

Funds